
DecisionDx®-SCC Informs Adjuvant Radiation Therapy Treatment Decisions for Patients with Cutaneous Squamous Cell ...
Sponsored by Castle Biosciences Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer in the United States, with almost 2 million cases diagnosed annually.1 This number has steadily increased in recent years and shows no signs of …